G G Nomikos

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness
    G G Nomikos
    Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285 0510, USA
    Behav Brain Res 113:97-103. 2000
  2. ncbi request reprint A role for cannabinoid CB1 receptors in mood and anxiety disorders
    J M Witkin
    Psychiatric Drug Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 0510, USA
    Behav Pharmacol 16:315-31. 2005
  3. ncbi request reprint The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus
    E T Tzavara
    Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
    Eur J Pharmacol 426:R3-4. 2001
  4. doi request reprint Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat
    R J Davis
    Mol Psychiatry 13:240-1. 2008

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness
    G G Nomikos
    Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285 0510, USA
    Behav Brain Res 113:97-103. 2000
    ..These results may also contribute to unraveling the cellular basis of nicotine's association with neuropsychiatric disorders, thereby offering the prospect of new therapeutic advances for their treatment...
  2. ncbi request reprint A role for cannabinoid CB1 receptors in mood and anxiety disorders
    J M Witkin
    Psychiatric Drug Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 0510, USA
    Behav Pharmacol 16:315-31. 2005
    ....
  3. ncbi request reprint The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus
    E T Tzavara
    Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
    Eur J Pharmacol 426:R3-4. 2001
    ..This increase in norepinephrine outflow could play an important role in the pharmacological and potentially therapeutic actions of SR141716A...
  4. doi request reprint Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat
    R J Davis
    Mol Psychiatry 13:240-1. 2008